Boston Partners increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 168.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 632,573 shares of the healthcare conglomerate’s stock after purchasing an additional 397,278 shares during the period. Boston Partners’ holdings in UnitedHealth Group were worth $232,233,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. boosted its stake in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the period. State Street Corp increased its stake in UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after buying an additional 301,081 shares during the period. Bank of America Corp DE increased its stake in shares of UnitedHealth Group by 21.8% during the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock valued at $3,169,606,000 after acquiring an additional 2,097,859 shares during the period. Fisher Asset Management LLC raised its stake in shares of UnitedHealth Group by 19.2% in the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock worth $3,975,343,000 after buying an additional 1,747,368 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Trading Down 5.5%
Shares of UNH opened at $330.58 on Friday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $296.21 billion, a PE ratio of 18.88, a price-to-earnings-growth ratio of 1.27 and a beta of 0.51. The stock’s fifty day simple moving average is $389.42 and its 200-day simple moving average is $367.27. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same period in the prior year, the business posted $2.59 earnings per share. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 annualized dividend and a dividend yield of 2.8%. UnitedHealth Group’s payout ratio is 53.00%.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on UNH shares. Barclays dropped their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 14th. Sanford C. Bernstein lowered their price target on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a report on Wednesday, October 14th. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a research note on Tuesday, October 27th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.
Check Out Our Latest Analysis on UNH
UnitedHealth Group News Summary
Here’s some of the latest news about UNH:
- Positive Sentiment: UnitedHealth raised its 2026 adjusted earnings outlook for the third time this year, to at least $20.50 per share. Recent premium increases, benefit reductions and exits from less-profitable markets helped lift its health-insurance operating margin to 3.3%. UnitedHealth Keeps Raising Guidance
- Positive Sentiment: Some coverage continues to see long-term growth potential in UnitedHealth, citing Optum’s scale and management’s target of 13%–16% long-term earnings growth. UnitedHealth’s Long-Term Earnings Growth Target
- Negative Sentiment: The main near-term headwind is a proposed CMS rule that would tighten Medicare Advantage audits and potentially allow recovery of overpayments dating back to 2018. Investors are concerned about the possible financial exposure; CMS estimates industry-wide recoveries could be substantial, but UnitedHealth’s share is not yet clear. The proposal has dragged down managed-care peers as well. Why UnitedHealth and Other Medicare Advantage Insurers Are Falling
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
